MAPK15 and non-small cell lung carcinoma: Our previous research revealed that MAPK15 promotes metastasis via its interaction with NF-κB subunit p50 and the transcriptional regulation of prostaglandin E2 receptor EP3 subtype in human non-small cell lung cancer (NSCLC) [13].